{
    "code": 0,
    "data": [
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report for 31st Dec 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28403a3c-f795-47cc-b110-ce1fcdb9b24b.pdf",
            "news_date": "2026-02-10 18:31:12"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release on Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b1b6dfd-d473-4e2c-8ab9-db1580537aa2.pdf",
            "news_date": "2026-02-09 19:23:03"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "6f25d94a-3f62-4bee-b22d-27b8b9c61813",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33df2677-efab-49bb-8997-d75763fea5db.pdf",
            "news_date": "2026-02-09 19:19:33",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33df2677-efab-49bb-8997-d75763fea5db.pdf",
            "news_date": "2026-02-09 19:19:33"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de233be5-e903-416e-a9dd-0d793d300cda.pdf",
            "news_date": "2026-02-09 18:50:57"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation Or Variation For The Quarter Ended  December 31 2025",
            "news_body": "Statement of Deviation or variation for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a8e11a7-7766-49e8-87df-89e6aea736d8.pdf",
            "news_date": "2026-02-07 16:56:09"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "Financial Results for the quarter ended 31st December 2025",
            "news_id": "7c4dff17-ed7f-46dc-b3e3-f74dd82cf3cf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8bd25be-2c18-4596-8f76-0c57ce9f6355.pdf",
            "news_date": "2026-02-07 16:43:06",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "Financial Results for the quarter ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8bd25be-2c18-4596-8f76-0c57ce9f6355.pdf",
            "news_date": "2026-02-07 16:43:06"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting And Financial Results",
            "news_body": "Financial results for the quarter ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c6fc775-5a29-4204-9269-012f53cf28a9.pdf",
            "news_date": "2026-02-07 16:37:24"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 inter alia to consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the third quarter ended on 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb4a2977-680f-4fee-aa8c-418acc93e790.pdf",
            "news_date": "2026-01-31 17:35:55"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window",
            "news_body": "Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a15a27e-78a9-4b9e-b4ca-4cc743755237.pdf",
            "news_date": "2026-01-17 15:18:01"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under 74(5) of SEBI(DP) Regulations  for the quarter ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14e290f1-7ccf-426d-878e-719763c564e3.pdf",
            "news_date": "2026-01-07 17:54:10"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of trading window for the third quarter ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=462cbc6d-6fec-4488-86f2-714ba65af18a.pdf",
            "news_date": "2025-12-29 14:55:44"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 - Investments In Subsidiary Company By Way Of Subscription Towards Rights Issue",
            "news_body": "Investment in Subsidiary Company by way of subscription towards right issue.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8bd02825-c710-400e-a9ff-38af2e9c36ef.pdf",
            "news_date": "2025-12-26 18:40:47"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Incorporation of wholly owned subsidiary company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af2a0ba2-ce2e-4420-bf3e-965fda0e1a62.pdf",
            "news_date": "2025-12-24 11:46:48"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Completion of USFDA inspection at vizag manufacturing facility",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47b2b7e9-a3b9-4e2a-9a4a-bcfcd6ac8400.pdf",
            "news_date": "2025-12-12 20:00:07"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Intimation of Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca59104c-d780-43c9-bdc7-7849864bf364.pdf",
            "news_date": "2025-12-04 09:58:58"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87262c23-398d-436b-974b-df77efe62e48.pdf",
            "news_date": "2025-11-26 08:22:58"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the conference call held on 11th November 2025",
            "news_id": "f97e755e-5330-422b-8295-8f7a2afe7faf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6582f724-b884-472c-977c-36e0c128a7e1.pdf",
            "news_date": "2025-11-13 18:19:07",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the conference call held on 11th November 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6582f724-b884-472c-977c-36e0c128a7e1.pdf",
            "news_date": "2025-11-13 18:19:07"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8312297b-9667-4606-9596-45da074fe2a0.pdf",
            "news_date": "2025-11-12 18:31:04"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 11 2025 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=D5660530_A79C_4DB0_AA9C_B3A5939891F9_170644.pdf",
            "news_date": "2025-11-11 17:06:49"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 11 2025 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9AF2A6C7_A1CB_4218_986A_1624624AB77F_154042.pdf",
            "news_date": "2025-11-11 15:40:47"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analyst/ Investor Conference call pertaining to the financial results for the quarter ended 30th September 2025",
            "news_id": "fc0e4984-c956-42bf-8507-e11c943397fd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1c5d052-3285-415c-9573-759d87ba5611.pdf",
            "news_date": "2025-11-11 14:49:03",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analyst/ Investor Conference call pertaining to the financial results for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1c5d052-3285-415c-9573-759d87ba5611.pdf",
            "news_date": "2025-11-11 14:49:03"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release on Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f02fe12-219c-46e2-9607-c834396e925f.pdf",
            "news_date": "2025-11-10 18:15:02"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation for the second quarter and half year ended 30th September 2025",
            "news_id": "3f71b630-0227-4d4f-82b2-567d4c625771",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=faca478f-827d-419a-a4dc-966a097596e8.pdf",
            "news_date": "2025-11-10 18:13:07",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation for the second quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=faca478f-827d-419a-a4dc-966a097596e8.pdf",
            "news_date": "2025-11-10 18:13:07"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of financial results for the second quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fa39844-9e9b-4c72-9865-b5cfe7b23592.pdf",
            "news_date": "2025-11-10 14:57:38"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation Or Variation For The Quarter Ended  September 30 2025",
            "news_body": "Statement of deviation or variation for the quarter ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c7e0041-652e-48a1-b015-b540e4276387.pdf",
            "news_date": "2025-11-08 14:26:25"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th September 2025",
            "news_body": "Financial results for the quarter ended 30th September 2025",
            "news_id": "1506c8e3-7346-4803-b670-4d7b2d97a0c0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9791afef-81a7-4ff4-b97f-178b1a53a02e.pdf",
            "news_date": "2025-11-08 14:21:18",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th September 2025",
            "news_body": "Financial results for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9791afef-81a7-4ff4-b97f-178b1a53a02e.pdf",
            "news_date": "2025-11-08 14:21:18"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting For Financial  Results",
            "news_body": "Approval of financial results for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea33673c-93d0-4989-b3fb-f1215403d6fc.pdf",
            "news_date": "2025-11-08 14:01:58"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Receipt Of Trading Approval From Stock Exchanges",
            "news_body": "This is to inform that Company has received trading approval for 5000000 equity shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eff03a2e-2ac8-4aee-af17-3e3218c6afbf.pdf",
            "news_date": "2025-11-07 15:26:55"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 04 2025 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=F58715FB_92B0_445E_8617_B9796EC264A7_105540.pdf",
            "news_date": "2025-11-06 10:55:45"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38FC8EB5_0B6F_461F_AB4C_1B9DB1F19921_092525.pdf",
            "news_date": "2025-11-06 09:25:30"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vistra ITCL (India) Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=FAA35FE8_AEE5_4DB3_81B2_6F419A0E0D4B_091256.pdf",
            "news_date": "2025-11-06 09:13:01"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Investors Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79f60c2a-490e-4d2b-b2c9-4943e5064953.pdf",
            "news_date": "2025-11-05 19:41:01"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window",
            "news_body": "Report on transfer requests of the physical  shares re-lodged under the special window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8805ee3d-4673-4e67-bb73-11a75f7b6eff.pdf",
            "news_date": "2025-11-05 11:57:59"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5D191917_7069_4DA3_BAD8_33FBFE25CA11_172030.pdf",
            "news_date": "2025-11-04 17:20:46"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30Th September 2025",
            "news_body": "SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 inter alia to consider and approve approval of Unaudited financial results for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f21c84c0-f50f-45ad-bc38-16e3cdd5e345.pdf",
            "news_date": "2025-11-03 10:18:45"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation under Regulation 30 of SEBI(LODR) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94e4dc14-b7e3-44ea-8eff-80a642d1c4eb.pdf",
            "news_date": "2025-10-16 12:28:27"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window",
            "news_body": "Report on transfer requests of physical shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f707a6c1-3ca9-45ec-9947-af7ba98a63d3.pdf",
            "news_date": "2025-10-10 18:10:16"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cff81f88-ab85-478b-a168-abfda88bea37.pdf",
            "news_date": "2025-10-10 17:03:39"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Combined Voting Results of 37th Annual Genera Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08341ea8-adfa-4a2f-92d7-acaf254f567c.pdf",
            "news_date": "2025-09-29 19:25:13"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Summary proceedings of the 37th AGM of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93f565f2-a170-43e1-8a8e-9211549cd7fb.pdf",
            "news_date": "2025-09-29 15:38:58"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of Trading window for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d72a533f-b694-4550-8ced-7f2dfa6f167b.pdf",
            "news_date": "2025-09-27 16:18:31"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vamsi Krishna Potluri & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=E6DA9082_6C81_4D94_AB08_44FFDF644FCF_125937.pdf",
            "news_date": "2025-09-13 12:59:46"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Trilok Potluri & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C19D56D4_A59C_4BCB_ADAA_3257AAD79976_125858.pdf",
            "news_date": "2025-09-13 12:59:03"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vamsi Krishna Potluri & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=CE5A3519_971A_4D63_8607_A6D3E08FE6D5_125627.pdf",
            "news_date": "2025-09-13 12:56:32"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Trilok Potluri & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9E450B21_66DE_4585_AD4C_7600CEE78C22_125558.pdf",
            "news_date": "2025-09-13 12:56:06"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Clarification On Volume/Price Movement",
            "news_body": "Clarification on Volume/ Price Movement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f93481bd-a144-402a-a5ed-c4cf09cdc6f7.pdf",
            "news_date": "2025-09-12 14:45:16"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from SMS Pharmaceuticals Ltd",
            "news_body": "The Exchange has sought clarification from SMS Pharmaceuticals Ltd on September 12 2025 with reference to Movement in Volume. <BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-09-12 13:20:36"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Meeting Updates",
            "caption": "Conversion Of 5000000 Warrants Into Equity Shares",
            "news_body": "Conversion of 5000000 warrants into equity shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9e86569-8535-4424-b401-39ef595ac48c.pdf",
            "news_date": "2025-09-10 18:52:23"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Conversion of Securities",
            "caption": "Announcement under Regulation 30 (LODR)-Conversion of Securities",
            "news_body": "Allotment of 5000000 Equity shares pursuant to conversion of warrants allotted on preferential basis.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=948b5fd7-0eda-4fdf-81e5-cdf26e4c5a76.pdf",
            "news_date": "2025-09-10 18:38:45"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication confirming dispatch of the Notice of the 37th AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d517e5b6-70b5-4af2-86e1-68f800f774ba.pdf",
            "news_date": "2025-09-08 15:03:21"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Dispatch Of Letter With Web-Link To Annual Report",
            "news_body": "Dispatch of letter with weblink of Annual Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87ac4aed-472c-4090-a73d-9bd9a75749f1.pdf",
            "news_date": "2025-09-06 22:39:47"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Report for the FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=866ca3e0-0074-4d2f-a9a2-df256b6b1f67.pdf",
            "news_date": "2025-09-06 20:59:31"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for the FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=288e889b-b882-4ec1-9ec1-c76bb1ebc2a8.pdf",
            "news_date": "2025-09-06 20:55:25"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 37Th Annual General Meeting And Annual Report For The FY 2024-25",
            "news_body": "Notice of 37th Annual General Meeting and Annual Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a1fea96-67e5-416b-9892-0a589ee7dd62.pdf",
            "news_date": "2025-09-06 20:34:53"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication informing about the 37th Annual General Meeting to be held through Video Conference/ Other Audio Visual means.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73d05e3a-bcfb-4009-b420-ca3f9c09ebce.pdf",
            "news_date": "2025-09-03 12:37:00"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Receipt of Establishment Inspection Report for Central Laboratory Analytical Services Hyderabad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49142a5d-e283-4777-bc2a-d344d1084079.pdf",
            "news_date": "2025-08-26 17:25:21"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vistra ITCL (India) Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=DF6B6CF3_99AC_4CBA_B267_10E9AF36220C_144314.pdf",
            "news_date": "2025-08-25 14:43:18"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on August 22 2025 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=EC6DB14D_8D44_44D0_A5B6_39DB3712B939_161724.pdf",
            "news_date": "2025-08-22 16:17:34"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 22 2025 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23EFA4FF_7798_4273_841B_B34706F19101_161433.pdf",
            "news_date": "2025-08-22 16:14:45"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10589177_EE19_49D8_87B7_7B7A24B2E669_155343.pdf",
            "news_date": "2025-08-22 15:53:49"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hima Hindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=D87BE922_5C56_4D70_9895_BD7A5C652C14_114111.pdf",
            "news_date": "2025-08-22 11:41:15"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on August 21 2025 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69F2CC8E_64E4_486D_B372_E428819076F8_104539.pdf",
            "news_date": "2025-08-22 10:45:44"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 21 2025 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1B846D96_9074_4EEB_A7FE_9678428602B4_103414.pdf",
            "news_date": "2025-08-22 10:34:19"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication regarding 100 days campaign-Saksham Niveshak",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2be9c223-82e1-467f-a40d-4de82b48d1e7.pdf",
            "news_date": "2025-08-21 19:34:27"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf70ed6b-5c95-4751-8a51-8946975868c3.pdf",
            "news_date": "2025-08-14 17:48:16"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cad8c3b-20b9-41a2-848f-2f93f31067fb.pdf",
            "news_date": "2025-08-11 11:20:31"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Investor Presentation On Financial Results",
            "news_body": "Investor Presentation on Financial Results for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf3dc633-7f8c-461c-958a-0758bcb8d10d.pdf",
            "news_date": "2025-08-10 21:48:11"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release on Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc90c94d-0b72-4bec-b2d9-e0b8cbc65574.pdf",
            "news_date": "2025-08-10 21:39:39"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter Ended June 30 2025",
            "news_body": "Financial Results for the quarter ended June 30 2025",
            "news_id": "490f9e1c-79f1-4406-a376-8050d64000e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11f9cec8-de8f-476f-852b-4915c6a17b75.pdf",
            "news_date": "2025-08-09 14:49:46",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results For The Quarter Ended June 30 2025",
            "news_body": "Financial Results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11f9cec8-de8f-476f-852b-4915c6a17b75.pdf",
            "news_date": "2025-08-09 14:49:46"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Record Date For The Purpose Of Determining The Members Eligible To Receive Dividend For The Financial Year 2024-25",
            "news_body": "Fixation of record date for determining the members eligible to receive dividend for the Financial Year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=575ab579-e6a7-4143-b17a-d34a250934aa.pdf",
            "news_date": "2025-08-09 14:04:12"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation Or Variation For The Quarter Ended  June 30 2025",
            "news_body": "Statement of Deviation or Variation for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=157b7645-df60-44d2-ae22-afd4e3d38c7f.pdf",
            "news_date": "2025-08-09 13:49:24"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting And Financial Results",
            "news_body": "Outcome of Board Meeting and Financial Results for the first quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20900454-c7a5-47d9-9e69-ff595d09b452.pdf",
            "news_date": "2025-08-09 13:32:32"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited (Standalone And Consolidated) Financial Results For The First Quarter Ended On 30Th June 2025",
            "news_body": "SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2025 inter alia to consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the first quarter ended on 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c899207-5106-45f3-aa4b-18a1b8561351.pdf",
            "news_date": "2025-08-02 18:06:02"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication for information regarding Special Window for Re-lodgment of transfer requests of physical shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecfa90f6-1ee5-4b25-af3a-57974b4d9002.pdf",
            "news_date": "2025-07-31 11:17:54"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa74a2ff-064d-4db4-8ee6-9c1295403b97.pdf",
            "news_date": "2025-07-10 11:21:37"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b58f900-93a4-48d5-a72f-f46f53badfe2.pdf",
            "news_date": "2025-07-10 10:47:38"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI LODR Regulations 2015 - Reminder Letter For Transfer Of Shares To Investor Education And Protection Fund (IEPF)",
            "news_body": "Reminder letter  for transfer of shares to IEPF is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eaec09b4-41e3-4510-b53c-a938ec08c31d.pdf",
            "news_date": "2025-07-08 18:48:56"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vistra ITCL (India) Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55A81B7A_FCA6_49DD_9A1A_653D75997ACD_090324.pdf",
            "news_date": "2025-07-03 09:03:38"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Re-Appointment of Mr. Vamsi Krishna Potluri as Whole Time Director designated as an  Executive Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=275fbc89-8e90-49c7-854b-e7c011ba166f.pdf",
            "news_date": "2025-07-01 17:20:23"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Re-appointment of Mr. Vamsi Krishna Potluri (DIN:06956498) as Whole Time Director of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6cfab623-642d-4077-a7a2-ee288a4a6cc4.pdf",
            "news_date": "2025-07-01 17:10:09"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Potluri Laboratories Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1BDBD513_CD17_4DE8_9EA8_9E408FB089B2_145257.pdf",
            "news_date": "2025-07-01 14:53:05"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Potluri Infra Projects LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8987F3E4_B286_4BF9_8F51_9E118338E48A_145117.pdf",
            "news_date": "2025-07-01 14:51:23"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on July 01 2025 for Potluri Laboratories Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0B4DC109_A67B_497D_9857_778922ED444B_135011.pdf",
            "news_date": "2025-07-01 13:50:26"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on July 01 2025 for Potluri Infra Projects LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5F762894_BCF0_430D_BDCD_3B937A7027AB_134844.pdf",
            "news_date": "2025-07-01 13:48:55"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 01 2025 for Potluri Laboratories Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=582A7E7F_B17E_41D4_957F_E841613BAA40_134516.pdf",
            "news_date": "2025-07-01 13:45:27"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 01 2025 for Potluri Infra Projects LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4C45117A_03FF_45FD_B146_CF5BB77BA406_134406.pdf",
            "news_date": "2025-07-01 13:44:17"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 30 2025 for Potluri Laboratories Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14F76F5C_4014_42C1_ADC7_65673B9E3B56_102102.pdf",
            "news_date": "2025-07-01 10:21:08"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 30 2025 for Potluri Infra Projects LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7B4793F9_5EFD_4BA7_9305_547F46B00D71_101937.pdf",
            "news_date": "2025-07-01 10:19:42"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 30 2025 for Potluri Laboratories Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=AD162B40_82CD_4E81_B97B_344D0D0B143C_101617.pdf",
            "news_date": "2025-07-01 10:16:25"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 30 2025 for Potluri Infra Projects LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4D0B596A_1D41_4522_A191_FDAA20FE4C78_101542.pdf",
            "news_date": "2025-07-01 10:15:54"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Potluri Laboratories Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C68DBFC5_5488_4807_81FC_1EB262FDD04B_194923.pdf",
            "news_date": "2025-06-30 19:49:27"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Potluri Infra Projects LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=136A4AF4_4290_43B9_95D0_DBF92B08E492_194806.pdf",
            "news_date": "2025-06-30 19:48:10"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of trading window for consideration of financial results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8535643-6f8a-4aa5-b3e3-c4ea77b2811e.pdf",
            "news_date": "2025-06-30 19:16:02"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 27 2025 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=536437BC_7276_4DFA_8A35_E51F4177A7B5_100708.pdf",
            "news_date": "2025-06-30 10:07:13"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 27 2025 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=B18411BF_FF66_429D_B4A5_F18A2B517EBC_100538.pdf",
            "news_date": "2025-06-30 10:05:43"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 27 2025 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C2D8BC5B_E064_494E_A5A9_BEC53BA1371B_095857.pdf",
            "news_date": "2025-06-30 09:59:04"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 27 2025 for Hima Bindu Potluri",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=DBE0E45D_45BC_4924_A26E_13DAF41AC09E_095431.pdf",
            "news_date": "2025-06-30 09:54:38"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR)  - Investments In Subsidiary Company By Way Of Subscription Towards Rights Issue",
            "news_body": "Investment in Subsidiary Company by way of subscription towards Rights Issue",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=faa7d3d8-f899-4d4e-8cd9-db9b88a2a231.pdf",
            "news_date": "2025-06-27 17:56:21"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI LODR Regulations",
            "news_body": "Register of application by NCLT.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=faa917e0-4959-4e11-9dd0-a1301a96523b.pdf",
            "news_date": "2025-06-26 19:45:44"
        },
        {
            "co_code": 25807,
            "bse_code": 532815,
            "isin": "INE812G01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Successful Completion Of USFDA Inspection At SMS Pharmaceuticals LimitedS Central Laboratory Analytical Services",
            "news_body": "Successful completion of USFDA inspection at SMS Pharmaceuticals Limiteds Central Laboratory Analytical Services.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53d1fe1a-e377-4c07-a219-f6d1c7b9a8ba.pdf",
            "news_date": "2025-06-25 16:13:22"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earning call geld on 2nd June 2025.",
            "news_id": "2ccfddaa-56f7-42d0-9cc2-de9e1fbac1dc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=129447e4-b59e-4b8a-9ae0-32f6f11dbe3e.pdf",
            "news_date": "2025-06-05 12:11:39",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investor call.",
            "news_id": "63081601-c6b4-494d-859d-e6b08057acd8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=420e6f20-7358-4b39-a96b-e21b4d6ad2e6.pdf",
            "news_date": "2025-06-02 15:17:07",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Quarter and year ended 31st March 2025",
            "news_id": "c8bf3147-6e6e-44ab-ab44-57ac2da45af2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc7bf01c-239a-42c0-9f95-ae55500f8d5e.pdf",
            "news_date": "2025-05-31 19:09:06",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Fourth Quarter And Year Ended 31St March 2025",
            "news_body": "Approved financial Results for the fourth quarter and year ended 31st March 2025",
            "news_id": "62fabf2e-cdf2-4bef-a805-26c7787aceeb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21e80d68-0c28-464e-9fb0-5f7236d21a23.pdf",
            "news_date": "2025-05-30 18:06:37",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results",
            "news_id": "4acc6195-7f5d-439a-b454-c27fd1e7d6bc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff07bb3a-0302-42c6-813c-c5fb07f3c3c0.pdf",
            "news_date": "2025-02-12 20:43:36",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31.12.2024",
            "news_body": "Financial Results for the quarter ended 31.12.2024",
            "news_id": "f1011688-8d06-4d48-8a73-b46335fdf4a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d7edaa3-00d1-45cd-a7e8-72f5ef641830.pdf",
            "news_date": "2025-02-12 14:21:51",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning Call held on 13.11.2024",
            "news_id": "f798edfe-9438-43fa-b896-3b93f5185477",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34d31f75-6e30-4a17-918f-3880dec6466c.pdf",
            "news_date": "2024-11-15 19:07:54",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors Call",
            "news_id": "a1ec7d1a-af60-47fb-afca-8162df181ecb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e292ffb2-9fa6-45fc-95a8-e62c1445f74e.pdf",
            "news_date": "2024-11-13 17:32:45",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Financial Results for the period ended 30th September 2024",
            "news_id": "5bc738ba-3ed0-4391-b2eb-e591f97611b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63c531a9-aa8d-446a-bc42-6b8552f00df8.pdf",
            "news_date": "2024-11-12 12:34:05",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The  Quarter Ended 30/09/2024",
            "news_body": "Financial Results for the quarte ended 30/09/2024",
            "news_id": "9eb09b71-5f27-476b-b44a-0e0103e49471",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e291bfcc-5a29-4e43-b1ae-e972ca9c3682.pdf",
            "news_date": "2024-11-08 18:57:44",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of conference call on 07th August, 2024",
            "news_id": "781466f3-7d4e-4e0a-9b4e-80e3707cabb9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=669f09d7-dcc3-402e-b261-05f50641e11b.pdf",
            "news_date": "2024-08-12 18:03:33",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the quarter ended 30th June, 2024",
            "news_id": "9dcfd6d4-7e8f-443c-8c38-296e8172486b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89d935ea-b0bf-4b20-be9a-bfe974a3e032.pdf",
            "news_date": "2024-08-07 15:17:48",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation of the Company for the quarter ended 30th June, 2024",
            "news_id": "21c01575-3a6b-4876-8519-04090b6e3e56",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08af0caa-a48d-4744-9bb5-380dfbe6e933.pdf",
            "news_date": "2024-08-06 17:58:03",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting And Financial Results.",
            "news_body": "Outcome of Board Meeting and Financial Results for the quarter ended 30th June, 2024.",
            "news_id": "3fdfebf6-f592-40e8-bda9-7ae2ab8f2d28",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b162293d-d868-4c14-b848-f04fb8b7780a.pdf",
            "news_date": "2024-08-05 15:23:51",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the fourth quarter and financial year ended 31st March, 2024",
            "news_id": "dc9976b6-b340-430a-89e4-def580f529a7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68f1b4d1-da23-4ffb-8e70-a248ff27d701.pdf",
            "news_date": "2024-05-31 15:52:24",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results",
            "news_id": "e49a6101-ec33-437f-a948-dae712bc5c20",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7af2fbfd-dd20-42c0-a96e-69ccbcf9fbad.pdf",
            "news_date": "2024-05-30 19:43:13",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Fourth Quarter And FY Ended 31St March, 2024",
            "news_body": "Financial Results for the Fourth quarter and FY ended 31st March, 2024",
            "news_id": "f1c06df7-ba9f-4379-b8c3-2c1b480d66e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61da9e9f-fdfb-460b-bf84-afefb98cb113.pdf",
            "news_date": "2024-05-29 13:33:39",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Investor call held on 12th February, 2024",
            "news_id": "ab0c66af-5a9a-4394-b20e-34e4e22ee484",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f1a3aa0-7109-426d-8f1f-fa5209effc0a.pdf",
            "news_date": "2024-02-12 19:10:56",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the third quarter ended 31st December, 2023",
            "news_id": "5ec57881-3137-4346-b661-d04a6c341d64",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77095d3c-3907-4eea-a9f8-2edece269e24.pdf",
            "news_date": "2024-02-10 16:23:57",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December, 2023",
            "news_body": "Financial Results for the quarter ended 31st December, 2023",
            "news_id": "94fd128d-4195-42b2-9a5e-bd2356bbff7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67718242-ce8f-47ad-a484-3432260dbf41.pdf",
            "news_date": "2024-02-08 19:04:26",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting - Approval Of Financial Results For The Quarter Ended 31St December, 2023 And Approval For Issue Of Share Warrants On Preferential Basis",
            "news_body": "Outcome of the Board Meeting - Approval of financial results for the quarter ended 31st December, 2023 and approval for issue of share warrants on preferential basis",
            "news_id": "ab47708e-59d4-48d0-b612-e114dec182c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35d96c0e-1d21-4374-a9df-5dcf9a82a51e.pdf",
            "news_date": "2024-02-08 19:01:06",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call",
            "news_id": "20714f2f-2b01-4e8c-b1d2-ea6bd2c6297f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6521349-1d68-4c59-bff0-7ca0aa1e0295.pdf",
            "news_date": "2023-11-10 17:28:52",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "bb0bdb73-5e0b-40de-a0d7-e58638e48d88",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18fd1da3-522e-4bdb-9576-f77f4719631c.pdf",
            "news_date": "2023-11-09 17:01:28",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome And Financial Results For The Quarter Ended 30Th September, 2023",
            "news_body": "Outcome and Financial Results for the quarter ended 30th September, 2023",
            "news_id": "07d68b9c-7596-4a77-900a-0810c1ec70a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f0c24fe-1d17-4ea9-9425-537ee679b8bf.pdf",
            "news_date": "2023-11-08 13:05:41",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Conference Call held on 10th August, 2023",
            "news_id": "1cb4a011-bd46-46df-a04a-8f9e325fc1c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c0ef820-a587-4428-99e0-205114cd388a.pdf",
            "news_date": "2023-08-17 17:22:48",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call",
            "news_id": "cd53c6a9-2310-46f3-828e-b99c71182002",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b48a5d1-9797-4e0a-9b83-50ad6eb5766d.pdf",
            "news_date": "2023-08-10 17:56:07",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results for the quarter ended 30.06.2023",
            "news_id": "40cff3a7-bd46-41bb-aeb9-8ae9244099fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a352d1a-84ef-4407-8780-cb3df7b10081.pdf",
            "news_date": "2023-08-09 18:50:13",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The First Quarter Ended 30Th June, 2023",
            "news_body": "Financial Results for the quarter ended 30th June, 2023",
            "news_id": "d3dae459-248f-4f31-9336-09bac4eccf00",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27eb689f-4fc9-4200-afa3-78a4c5a1fef4.pdf",
            "news_date": "2023-08-08 13:54:13",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call",
            "news_id": "c78b7046-37cb-421d-b1df-0a77925e2782",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e68a53eb-ee5b-4da1-a737-b0a008b74440.pdf",
            "news_date": "2023-05-26 17:32:04",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "81b6de7d-248f-49f0-984a-656e09e4f2de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3557221d-bd19-4e5a-b298-27753a154d97.pdf",
            "news_date": "2023-05-25 19:08:51",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Fourth Quarter And Year Ended 31.03.2023",
            "news_body": "Outcome of Board Meeting and Financial Results",
            "news_id": "78d65d84-599a-4402-af88-a6287981dad2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9d1bbf9-24b0-426c-9a05-bdf611a6b75d.pdf",
            "news_date": "2023-05-24 13:29:27",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting And Financial Results",
            "news_body": "Outcome of Board Meeting and Financial Results",
            "news_id": "59efe2b8-e8ec-4659-bf81-5edd304e5576",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=026787e0-4288-42d2-88e9-a84922b8d472.pdf",
            "news_date": "2023-05-24 13:23:35",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Conference Call held on 10th February, 2023.",
            "news_id": "06bd94aa-b887-4f13-9988-5d1818f4e731",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ac7f779-22ac-4d1a-86a7-911a4f8faff8.pdf",
            "news_date": "2023-02-14 18:59:53",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call",
            "news_id": "dae0f761-24be-4fdd-8c56-36bd9af5d38c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd24be50-6896-4408-9b9c-bdc8a8e44243.pdf",
            "news_date": "2023-02-10 15:32:24",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "d2c48a8d-e494-4462-8bfd-3f3590660712",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dcb9568-a17f-4d93-90d5-8dee9930c7e1.pdf",
            "news_date": "2023-02-09 18:52:53",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December, 2022",
            "news_body": "Financial Results for the quarter ended 31st December, 2022",
            "news_id": "50f0a62c-cfe1-436c-a540-5eec560db0ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee07994a-1435-446f-92e2-d170a025c574.pdf",
            "news_date": "2023-02-09 12:31:25",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting And Financial Results",
            "news_body": "Outcome of Board Meeting held on 09th February, 2023",
            "news_id": "798056f3-fbe0-4979-b3b0-99422a8d8862",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a093f38-3355-42aa-ae10-46f1cb9abaf7.pdf",
            "news_date": "2023-02-09 12:24:14",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2022",
            "news_body": "Disclosure of Related Party Transactions for the half year ended 30th September, 2022",
            "news_id": "bcdcfc64-7273-4156-a40b-4e5e2dfb2b04",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d289d16c-75cd-4196-b69a-825ba7f9139a.pdf",
            "news_date": "2022-11-22 17:21:02",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call",
            "news_id": "e95be7e1-a154-440a-8431-4d56d1e93224",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a6042ed-18da-448e-85c9-89be1e8c015f.pdf",
            "news_date": "2022-11-17 18:26:42",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "standalone and consolidated un-audited Financial Results for the quarter and half year ended 30th September, 2022",
            "news_id": "df60f33d-e8de-48f2-8ec8-5cfb25d829c4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97769382-4662-41c3-9c72-85fcb682f91e.pdf",
            "news_date": "2022-11-12 11:32:08",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 12-Nov-2022 To Consider Financial Statements For The Period Ended September 2022",
            "news_body": "outcome of the Board Meeting held on 12-Nov-2022 to consider financial statements for the period ended September 2022",
            "news_id": "abc8b1d8-a57e-47ab-a7de-8b09e468e40b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7453f09d-4a34-4c55-8472-d7341a8fbbb5.pdf",
            "news_date": "2022-11-12 11:27:15",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Auditor''s Limited Review Report For The Consolidated Financials Results For The Quarter Ended 30Th June 2022",
            "news_body": "We are herewith submitting Revised Auditor''s Limited Review Report for the Consolidated Financials Results against the quarter ended 30th June 2022",
            "news_id": "9ad54faf-f8fb-416a-9e8d-c1b51d4711fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fe9ed33-e083-436f-ac10-7d5cef01da80.pdf",
            "news_date": "2022-09-13 12:59:17",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of the Company for the first Quarter ended 30th June, 2022.",
            "news_id": "31fecd31-0142-46fe-81f0-6fb8c960bfdb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0827ec5-dc7a-4d68-9a3a-e1bb26809b4c.pdf",
            "news_date": "2022-08-13 17:02:47",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of the Company for the first Quarter ended 30th June, 2022.",
            "news_id": "fa8c0186-8f19-4c80-8d41-6a9d22525816",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb94dc59-02b8-4655-85aa-60b0c0c02062.pdf",
            "news_date": "2022-08-13 17:01:02",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The First Quarter Ended 30Th June, 2022",
            "news_body": "Financial Results for the first quarter ended 30th June, 2022",
            "news_id": "90c90e48-1b8d-4ec7-aa54-8e97045507bf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a0f26f6-8ea9-4f56-ab48-2a60dfbfc9fe.pdf",
            "news_date": "2022-08-13 13:30:35",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for  Board Meeting Held On 13-Aug-2022 To Consider Financial Statements For The Period Ended June 2022 And Other Business Matters",
            "news_body": "SMS Pharmaceuticals Limited  has informed the Exchange about Board Meeting held on 13-Aug-2022 to consider financial statements for the period ended June 2022 and Other business matters",
            "news_id": "2c6936e7-978d-4986-aed4-cdc9b9abd3db",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80884c9b-8c94-49a7-834b-c4b3712bef38.pdf",
            "news_date": "2022-08-13 13:26:26",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2022",
            "news_body": "Disclosure of Related Party Transactions for the half year ended 31st March, 2022",
            "news_id": "314f87a1-c1e0-447b-929e-0ecf854e55e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d362000c-27a5-47a6-9c41-06383c6204d9.pdf",
            "news_date": "2022-06-07 15:47:58",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q4 & FY 2022 Financial Results",
            "news_id": "050f46ad-5bf4-4a1d-83e9-ecee5f4375e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22aa3315-e4ac-401f-a31b-664b15ced7d2.pdf",
            "news_date": "2022-06-02 15:33:37",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Correction In The Notes To Financial Results Submitted For The Quarter And Year Ended 31St March, 2022",
            "news_body": "Correction in the Notes to Financial Results submitted for the Quarter and Year ended 31st March, 2022<BR>",
            "news_id": "6d69d895-d122-4fa4-879c-d0a494d1d0cf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89861129-f703-47cd-99b7-cbbbf78e946a.pdf",
            "news_date": "2022-05-30 19:14:56",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th May, 2022",
            "news_body": "Outcome of Board Meeting held on 30th May, 2022<BR>",
            "news_id": "59109131-3c3d-4b4a-8114-ee562c79c880",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d9c430d-93ad-4939-bdb1-ef5a87d22f1b.pdf",
            "news_date": "2022-05-30 14:07:06",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 9Th February, 2022",
            "news_body": "With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held today, inter-alia considered and approved the following:<BR> <BR> 1. The Standalone and Consolidated Un-audited Financial Results for the third Quarter and Nine months ended 31st December, 2021 along with the Limited Review Report.<BR> <BR>",
            "news_id": "04337def-9bf8-4955-8537-b39c0f2895b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1eded5b5-8af1-4067-bf5b-0d66b213cbba.pdf",
            "news_date": "2022-02-09 13:02:40",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a herewith a copy of investor presentation of the Company.<BR> This Investor Presentation may also be accessed on the website of the Company at www.smspharma.com<BR>",
            "news_id": "522f2d84-d869-4f8a-98ca-cb9c77677f7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68201631-9d90-47c6-b677-097d3c4373de.pdf",
            "news_date": "2021-11-13 14:13:09",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 12Th November, 2021",
            "news_body": "With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held today, inter-alia considered and approved the following:<BR> <BR> 1. The Standalone and Consolidated Un-audited Financial Results for the Quarter and half year ended 30th September, 2021 along with the Limited Review Report.<BR> <BR> 2. Approved the resignation of Mr. V S Venkatish, Company Secretary and Compliance Officer, and he will be relieved on or before 31st January, 2022.<BR>",
            "news_id": "5d8bef2a-9f8b-4c4d-b89e-e10e234b9d69",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1ad2b33-736d-446c-b0ee-cb1e33f65095.pdf",
            "news_date": "2021-11-12 14:02:19",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a herewith a copy of investor presentation of the Company.",
            "news_id": "a7bf08fa-453a-4c29-955d-4b9c3d40afb9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f713eb0-e46c-421e-8cf9-f3a57d577612.pdf",
            "news_date": "2021-10-28 17:23:18",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 7Th August, 2021 - Revised",
            "news_body": "With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held on today, inter-alia considered and approved the following:<BR> <BR> 1. Approved the Standalone and Consolidated Un-audited Financial Results for the Quarter ended 30th June, 2021 along with the Limited Review Report<BR> 2. Reclassification of promoter group shareholding from promoter category to public category.<BR> 3. Directors Report by the Board for the FY 2020-21<BR> 4. Convening the 33rd Annual General Meeting on 30th, September, 2021 <BR> 5. Dividend Distribution Policy<BR>",
            "news_id": "e86fb101-c8bc-4c6f-a5fa-eb739ce79935",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78ea5a82-a738-425f-827a-3032cc7cc47c.pdf",
            "news_date": "2021-08-07 14:38:53",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 7Th August, 2021",
            "news_body": "With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held on today, inter-alia considered and approved the following:<BR> <BR> 1. Approved the Standalone and Consolidated Un-audited Financial Results for the Quarter ended 30th June, 2021 along with the Limited Review Report<BR> 2. Reclassification of promoter group shareholding from promoter category to public category.<BR> 3. Directors Report by the Board for the FY 2020-21<BR> 4. Convening the 33rd Annual General Meeting on 30th, September, 2021 <BR> 5. Dividend Distribution Policy<BR>",
            "news_id": "b666bf11-d801-4fea-879b-218fbad46a49",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c3669d9-1853-4f00-b534-8ef72747890d.pdf",
            "news_date": "2021-08-07 13:06:43",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board meeting held on 28th May, 2021.",
            "news_id": "91711557-6bec-4b6d-9682-0bae19e98fc1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39b8263d-8241-412a-84f0-dae3be3a56ea.pdf",
            "news_date": "2021-05-28 17:12:31",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}